Cleared Traditional

K812986 - AGGLUTEX AMPHETAMINE TEST KIT
(FDA 510(k) Clearance)

Jan 1982
Decision
88d
Days
Class 2
Risk

K812986 is an FDA 510(k) clearance for the AGGLUTEX AMPHETAMINE TEST KIT. This device is classified as a Radioimmunoassay, Amphetamine (Class II - Special Controls, product code DJP).

Submitted by Hoffmann-La Roche, Inc. (Mchenry, US). The FDA issued a Cleared decision on January 22, 1982, 88 days after receiving the submission on October 26, 1981.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3100.

Submission Details

510(k) Number K812986 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 26, 1981
Decision Date January 22, 1982
Days to Decision 88 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary

Device Classification

Product Code DJP — Radioimmunoassay, Amphetamine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3100

Similar Devices — DJP Radioimmunoassay, Amphetamine

All 8
PRIMIDONE EIA TEST
K960526 · Diagnostic Reagents, Inc. · Mar 1996
URINE AMPHETAMINE DIRECT RIA KIT (I-125)
K913866 · Immunalysis Corporation · Sep 1991
ABUSCREEN RADIOIMMUNOASSAY FOR AMPHETAMINE
K912755 · Roche Diagnostic Systems, Inc. · Aug 1991
REVISED DOUBLE ANTIBODY AMPHETAMINE
K882228 · Diagnostic Products Corp. · Aug 1988
ABUSCREEN(R) ONTRAK(TM) FOR AMPHETAMINES
K881817 · Roche Diagnostic Systems, Inc. · Jul 1988
ABUSCREEN RADIOIMMUNOASSAY FOR AMPHETAMINE-HIGH SP
K854009 · Roche Diagnostic Systems, Inc. · Oct 1985